Bisoprolol Fumarate

Bisoprolol Fumarate

Produktname Bisoprolol Fumarate
CAS-Nummer 104344-23-2
Molekülformel C18H31NO4 · ½ C4H4O4
Molekulargewicht 766.96 g/mol (as fumarate salt)
Aussehen Weißes bis cremefarbenes kristallines Pulver
Analyse (HPLC) 98.0% – 102.0% (on dried basis)
Trocknungsverlust ≤ 0,5%
Verbrennungsrückstand ≤ 0.1%
Schwermetalle ≤ 10 ppm
Löslichkeit Sparingly soluble in water, freely soluble in methanol, slightly soluble in ethanol
Verpackung 25 kg net in fiber drum with double polyethylene liner

Brauchst du Hilfe? Kontaktieren Sie unser Team

Bisoprolol Fumarate Structure

Synonyme: Bisoprolol fumarate, 104344-23-2, EMD 33512, Bisoce, Bisoprolol hemifumarate, (±)-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol fumarate

Bisoprolol fumarate is a synthetic, cardioselective beta-1 adrenergic receptor blocker belonging to the aminoxypropanol class. It is supplied as a white to off-white crystalline powder, manufactured under cGMP conditions and tested to meet or exceed current pharmacopoeial standards (USP/EP).

As a highly selective beta-1 antagonist, bisoprolol fumarate is a cornerstone API for the treatment of hypertension, chronic stable angina, and heart failure. Its balanced lipophilicity and long half-life make it suitable for once-daily dosing, and it remains a preferred choice among healthcare professionals for cardiovascular management.

Product Highlights

  • High purity: ≥98.0% assay, with tight control on related substances and residual solvents.
  • Regulatory support: Available with DMF (Type II) and CEP, suitable for ANDA and generic filings.
  • Stable supply: Commercial-scale production with a current capacity of 20 metric tons per year.
  • Quality assurance: Each batch is fully traceable, with full documentation and retained samples.
  • Competitive pricing: Direct from manufacturer, offering cost advantages for bulk orders.

Anwendungen

  • Treatment of essential hypertension, either as monotherapy or in combination with other antihypertensives.
  • Management of chronic stable angina pectoris.
  • Adjunct therapy in stable chronic heart failure with reduced ejection fraction.
  • Formulation of immediate-release and fixed-dose combination tablets.
  • Research on beta-adrenergic receptor pharmacology and cardiovascular therapeutics.

Technische Daten

Parameter Technische Daten
Assay (HPLC, dried basis) 98.0% – 102.0%
Aussehen Weißes bis cremefarbenes kristallines Pulver
Identification IR and HPLC retention time match reference standard
Trocknungsverlust ≤ 0,5%
Verbrennungsrückstand ≤ 0.1%
Schwermetalle ≤ 10 ppm
Related Substances Each impurity ≤ 0.5%, total ≤ 1.0%

Ordering & Supply

  • Verpackung: 25 kg net in fiber drum with double polyethylene liner; custom packaging available upon request.
  • Mindestbestellmenge: 1 kg for trial orders; 25 kg for commercial orders.
  • Lieferzeit: 3–5 Werktage (Lagerware)
  • Dokumentation: COA, MSDS, TDS, and regulatory support (DMF, CEP) provided with each shipment.

Angebotsanfrage

BLEIBEN SIE IN KONTAKT

Angebotsanfrage

Unsere Adresse

Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China

✅ ×